Filing Details
- Accession Number:
- 0001140361-12-032153
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-03 15:06:54
- Reporting Period:
- 2012-07-02
- Filing Date:
- 2012-07-03
- Accepted Time:
- 2012-07-03 14:06:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1037760 | Cepheid | CPHD | Laboratory Analytical Instruments (3826) | 770441625 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1240656 | H Joseph Smith | C/O Cepheid 904 Caribbean Drive Sunnyvale CA 94089 | Svp, Bus Dev And Gc | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-07-02 | 9,134 | $4.30 | 15,606 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2012-07-02 | 9,600 | $9.11 | 25,206 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-07-02 | 9,134 | $45.50 | 16,072 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-07-02 | 9,600 | $46.00 | 6,472 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified stock option (right to buy) | Disposition | 2012-07-02 | 9,134 | $0.00 | 9,134 | $4.30 |
Common Stock | Non-qualified stock option (right to buy) | Disposition | 2012-07-02 | 9,600 | $0.00 | 9,600 | $9.11 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10 | 2014-04-25 | No | 4 | M | Direct | |
38,400 | 2016-04-26 | No | 4 | M | Direct |
Footnotes
- The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 30, 2011.
- The stock option grant is 100% vested and exercisable.